## **Core Concept**
The management of hypertension in patients with diabetes mellitus requires careful consideration of the antihypertensive agent's effects on glucose metabolism, renal function, and cardiovascular risk. The primary goal is to reduce blood pressure while minimizing adverse effects on glucose control and renal function.

## **Why the Correct Answer is Right**
The correct answer, **C. ACE inhibitors (or ARBs)**, is supported by evidence that these classes of medications are particularly beneficial for patients with diabetes. ACE inhibitors (e.g., lisinopril) and ARBs (e.g., losartan) have been shown to slow the progression of diabetic nephropathy by reducing intraglomerular pressure and proteinuria. They do not adversely affect glucose control and have a protective effect on the kidneys.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Beta blockers can be used in hypertension but are not the first choice in diabetes as they may mask symptoms of hypoglycemia and can have negative effects on glucose metabolism.
- **Option B:** Calcium channel blockers are effective in lowering blood pressure but do not offer the same renal protective effects as ACE inhibitors or ARBs in diabetic patients.
- **Option D:** Diuretics, especially thiazide diuretics, can lead to worsening glucose tolerance and are not considered first-line in diabetic patients due to potential negative effects on glucose metabolism and electrolyte balance.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that ACE inhibitors and ARBs are considered first-line antihypertensive agents in patients with diabetes due to their protective effects on the kidneys. They can help reduce the risk of diabetic nephropathy and are recommended even in the absence of proteinuria or renal impairment.

## **Correct Answer:** . **C. ACE inhibitors (or ARBs)**